@article{ATM34785,
author = {Rishi Chandiramani and Davide Cao and Roxana Mehran},
title = {Periprocedural anticoagulation in non-ST-segment elevation acute coronary syndrome: time to reassess?},
journal = {Annals of Translational Medicine},
volume = {8},
number = {8},
year = {2020},
keywords = {},
abstract = {Non-ST-segment elevation acute coronary syndromes (NSTE-ACS) are responsible for almost 1 million admissions in the U.S. annually (1), and represent a spectrum of clinical conditions ranging from unstable angina (UA) to non-ST-segment elevation myocardial infarction (NSTEMI). The most important cause is intraluminal thrombosis due to atherosclerotic plaque rupture, which impairs distal blood flow and may lead to myocardial ischemia or infarction.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/34785}
}